Patients Professionals Investors Distributors
Investor Relations

HemoSense was acquired by Inverness Medical Innovations in November 2007.

HemoSense develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication.

Recent Press Releases
» see Inverness Medical Innovations releases

» see HemoSense releases (before November 2007)


Company Contact:
HemoSense, Inc.
(408) 719-1393 tel
(408) 719-1184 fax

   
Inverness
IMA (AMEX)
Price $35.56
Change 0.40 (1.11%)
Day High 36.00
Day Low 35.50
52 Week High 65.00
52 Week Low 26.29
Daily Volume 238,100
As of 4:09 PM ET on Aug 28, 2008
Market data powered by TurboFeed.
Quotes delayed at least 15 minutes.

Investor Info
Home Company Contact